Cargando…

Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework

In this research, zirconium-based metal–organic framework was utilized as a novel and efficient porous adsorbent for headspace extraction of Amphetamine, Methamphetamine, and Fenfluramine from the urine samples by a needle trap device (NTD). The Zr-UiO-66-PDC was electrosynthesized at the green cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimpoor, Razzagh, Firoozichahak, Ali, Alizadeh, Saber, Nematollahi, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372183/
https://www.ncbi.nlm.nih.gov/pubmed/35953701
http://dx.doi.org/10.1038/s41598-022-17861-1
_version_ 1784767324513894400
author Rahimpoor, Razzagh
Firoozichahak, Ali
Alizadeh, Saber
Nematollahi, Davood
author_facet Rahimpoor, Razzagh
Firoozichahak, Ali
Alizadeh, Saber
Nematollahi, Davood
author_sort Rahimpoor, Razzagh
collection PubMed
description In this research, zirconium-based metal–organic framework was utilized as a novel and efficient porous adsorbent for headspace extraction of Amphetamine, Methamphetamine, and Fenfluramine from the urine samples by a needle trap device (NTD). The Zr-UiO-66-PDC was electrosynthesized at the green conditions and characterized by various analyses such as FT-IR, XRD, FE-SEM, EDS, and elemental mapping techniques. Then, the effective parameters on the NTD efficiency such as salt content, pH, extraction/desorption temperature and time were evaluated and optimized by response surface methodology. The optimal extraction of amphetamine compounds was accomplished in 50 min at 70 ºC at the situation with NaCl content of 27% and pH: 11.90. The limit of detection, and limit of quantification factors were determined to be 0.06–0.09 and 0.5–0.8 ng mL(−1), respectively. Furthermore, the precision and accuracy (intra- and inter-day) of the employed procedure in the term of relative standard deviation (RSD) were calculated in the range of 8.0–9.0% and 6.8–9.8%, respectively. Also, the recovery percent of the extracted analytes were concluded in the range of 95.0–97.0% after 10 days from the sampling and storage at 4 °C. Finally, the proposed procedure was involved in the analysis of amphetamine compounds in the real urine samples. These results were proved the proposed Zr-UiO-66-PDC@HS-NTD technique coupled with GC-FID can be used as an eco-friendly, fast-response, sensitive, and efficient drug test procedure for trace analysis of the amphetamine compounds in urine samples.
format Online
Article
Text
id pubmed-9372183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93721832022-08-13 Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework Rahimpoor, Razzagh Firoozichahak, Ali Alizadeh, Saber Nematollahi, Davood Sci Rep Article In this research, zirconium-based metal–organic framework was utilized as a novel and efficient porous adsorbent for headspace extraction of Amphetamine, Methamphetamine, and Fenfluramine from the urine samples by a needle trap device (NTD). The Zr-UiO-66-PDC was electrosynthesized at the green conditions and characterized by various analyses such as FT-IR, XRD, FE-SEM, EDS, and elemental mapping techniques. Then, the effective parameters on the NTD efficiency such as salt content, pH, extraction/desorption temperature and time were evaluated and optimized by response surface methodology. The optimal extraction of amphetamine compounds was accomplished in 50 min at 70 ºC at the situation with NaCl content of 27% and pH: 11.90. The limit of detection, and limit of quantification factors were determined to be 0.06–0.09 and 0.5–0.8 ng mL(−1), respectively. Furthermore, the precision and accuracy (intra- and inter-day) of the employed procedure in the term of relative standard deviation (RSD) were calculated in the range of 8.0–9.0% and 6.8–9.8%, respectively. Also, the recovery percent of the extracted analytes were concluded in the range of 95.0–97.0% after 10 days from the sampling and storage at 4 °C. Finally, the proposed procedure was involved in the analysis of amphetamine compounds in the real urine samples. These results were proved the proposed Zr-UiO-66-PDC@HS-NTD technique coupled with GC-FID can be used as an eco-friendly, fast-response, sensitive, and efficient drug test procedure for trace analysis of the amphetamine compounds in urine samples. Nature Publishing Group UK 2022-08-11 /pmc/articles/PMC9372183/ /pubmed/35953701 http://dx.doi.org/10.1038/s41598-022-17861-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Rahimpoor, Razzagh
Firoozichahak, Ali
Alizadeh, Saber
Nematollahi, Davood
Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title_full Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title_fullStr Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title_full_unstemmed Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title_short Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
title_sort urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal–organic framework
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372183/
https://www.ncbi.nlm.nih.gov/pubmed/35953701
http://dx.doi.org/10.1038/s41598-022-17861-1
work_keys_str_mv AT rahimpoorrazzagh urinarybiomonitoringofamphetaminederivativesbyneedletrapdevicepackedwiththezirconiumbasedmetalorganicframework
AT firoozichahakali urinarybiomonitoringofamphetaminederivativesbyneedletrapdevicepackedwiththezirconiumbasedmetalorganicframework
AT alizadehsaber urinarybiomonitoringofamphetaminederivativesbyneedletrapdevicepackedwiththezirconiumbasedmetalorganicframework
AT nematollahidavood urinarybiomonitoringofamphetaminederivativesbyneedletrapdevicepackedwiththezirconiumbasedmetalorganicframework